Summary
Centene Corporation (CNC) has announced the pricing of a $1.8 billion offering of 2.450% Senior Notes due 2028. The primary purpose of this debt issuance is to finance a portion of the cash consideration for its previously announced acquisition of Magellan Health Inc. This offering provides crucial funding for a significant strategic move by Centene, aiming to expand its healthcare services and market reach. The closing of the note offering is independent of the Magellan Health acquisition closing. Should the acquisition not materialize, Centene plans to utilize the net proceeds for debt repayment and general corporate purposes. This provides a degree of financial flexibility and risk mitigation for the company, ensuring the capital is deployed constructively regardless of the acquisition's outcome. Investors should monitor the progress of the Magellan Health acquisition and Centene's overall debt management strategy.
Key Highlights
- 1Centene Corporation is issuing $1.8 billion in aggregate principal amount of 2.450% Senior Notes due 2028.
- 2The offering is being conducted through an Underwriting Agreement with J.P. Morgan Securities LLC, as representative of the underwriters.
- 3Proceeds are intended to fund a portion of the cash consideration for the acquisition of Magellan Health Inc.
- 4The closing of the note offering is not contingent on the closing of the Magellan Health acquisition.
- 5If the Magellan Acquisition is not completed, proceeds will be used for debt repayment and general corporate purposes.
- 6The company issued press releases on June 24, 2021, announcing the commencement and pricing of the Offering.